GSK's Discovery Fast Track Competition, which aims to establish direct collaborations with academic researchers, hit a road block when the UCLA Office of Intellectual Property said that UCLA researchers cannot participate. The head of that office believes GSK is doing an end-run around traditional IP vetting by tech transfer offices and that his policy should be UC system-wide.